NextPlat (NXPL) Gross Profit Growth (3y) (2018 - 2026)
Powered by 
Analysis
NextPlat (NXPL) Gross Profit Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 6.23% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -3.26% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -6.56% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 14.99% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 11.19% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 30.72% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 8.72% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 75.43% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 77.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.17% |
| Mar 31, 2026 | 76.46% |
| Dec 31, 2025 | 60.60% |
| Sep 30, 2025 | 59.03% |
| Jun 30, 2025 | 71.92% |
| Mar 31, 2025 | 52.91% |
| Dec 31, 2024 | 91.67% |
| Sep 30, 2024 | 93.23% |
| Jun 30, 2024 | 121.17% |
| Mar 31, 2024 | 123.17% |
| Dec 31, 2023 | 187.62% |
| Sep 30, 2023 | 125.76% |
| Jun 30, 2023 | 48.51% |
| Mar 31, 2023 | 21.29% |
| Dec 31, 2022 | 11.02% |
| Sep 30, 2022 | 21.28% |
| Jun 30, 2022 | 27.44% |
| Mar 31, 2022 | 48.24% |
| Dec 31, 2021 | 93.56% |
| Sep 30, 2021 | 26.05% |